Production (Stage)
Nika Pharmaceuticals, Inc.
NIKA
$0.6495
-$0.0004-0.06%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -22.04% | -89.29% | -87.16% | -32.43% | 444.44% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -15.66% | -8.67% | -87.16% | 1,900.90% | 822.22% |
|
|||||
Total Current Assets | -15.66% | -8.67% | -87.16% | 1,900.90% | 822.22% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -15.66% | -8.67% | -87.16% | 3,416.22% | 822.22% |
|
|||||
Total Accounts Payable | -- | -- | -- | -- | -- |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | 4.91% | 135.20% | 145.27% | 735.27% | 521.31% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 1.20% | 135.20% | 145.27% | 741.35% | 544.07% |
|
|||||
Total Current Liabilities | 1.20% | 135.20% | 145.27% | 741.35% | 544.07% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 4.91% | 135.20% | 145.27% | 735.27% | 521.31% |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 1.20% | 135.20% | 145.27% | 741.35% | 544.07% |
|
|||||
Common Stock & APIC | -0.01% | 162.43% | 162.43% | 162.52% | 162.44% |
Retained Earnings | -0.11% | -162.56% | -162.76% | -164.75% | -166.20% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -4.52% | -167.99% | -177.44% | -277.63% | -494.99% |
|
|||||
Preferred Stock Redeemable | 50.00% | 50.00% | 50.00% | 50.00% | 0.00% |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 50.00% | 50.00% | 50.00% | 50.00% | 0.00% |
|
|||||
Total Common Equity | -4.52% | -167.99% | -177.44% | -277.63% | -494.99% |
Total Preferred Equity | 50.00% | 50.00% | 50.00% | 50.00% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -4.32% | -169.43% | -179.14% | -281.14% | -508.40% |
|